Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Air Products & Chemicals, Inc. | 42,813.63 | reported | 30 Sept 2020 | tx 77+41,751.58 |
| NOVAVAX INC | 28,326 | reported | 20 Jun 2025 | tx 23+130,628−20,890 |
| MERCK & CO INC | 7,650 | reported | 24 Apr 2009 | tx 38+419,448.413−109,178.303 |
| VERTEX PHARMACEUTICALS INC / MA | 3,481 | reported | 01 May 2023 | tx 85+353,244−212,055 |
| AMICUS THERAPEUTICS, INC. | 0 | reported | 27 Apr 2026 | tx 62+622,987−588,261 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 94,631 | 14.50 USD | |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 20,000 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 16,236 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 19,473 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 18,574 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 36,111 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 45,423 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 30,474 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 42,467 | — | deriv |
| 27 Apr 2026 | OTHER | AMICUS THERAPEUTICS, INC. | 74,872 | — | deriv |
| 20 Jun 2025 | GRANT_AWARD | NOVAVAX INC | 28,326 | 6.42 USD | deriv |
| 20 Jun 2025 | GRANT_AWARD | NOVAVAX INC | 18,884 | 0.00 USD | deriv |
| 12 Jun 2025 | EXERCISE | NOVAVAX INC | 10,420 | 0.00 USD | |
| 12 Jun 2025 | EXERCISE | NOVAVAX INC | 10,420 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | AMICUS THERAPEUTICS, INC. | 20,414 | 0.00 USD | |
| 05 Jun 2025 | GRANT_AWARD | AMICUS THERAPEUTICS, INC. | 74,872 | 0.00 USD | deriv |
| 30 Jun 2024 | GRANT_AWARD | NOVAVAX INC | 713 | 13.93 USD | |
| 30 Sept 2024 | GRANT_AWARD | NOVAVAX INC | 778 | 12.77 USD | |
| 31 Dec 2024 | GRANT_AWARD | NOVAVAX INC | 1,178 | 8.61 USD | |
| 31 Mar 2024 | GRANT_AWARD | NOVAVAX INC | 2,029 | 4.90 USD | |
| 12 Jun 2024 | EXERCISE | NOVAVAX INC | 6,670 | 0.00 USD | |
| 12 Jun 2024 | EXERCISE | NOVAVAX INC | 6,670 | 0.00 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | NOVAVAX INC | 15,630 | 15.86 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | NOVAVAX INC | 10,420 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | AMICUS THERAPEUTICS, INC. | 11,847 | 0.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 10 Nov 2015.